Article · 5 Oct 2026
Conference abstract
Eprosartan mesylate co-crystals and their enhanced oral bioavailability studies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Co-crystallization is a useful technique for the enhancement of the physicochemical properties of the molecules. The poor physiochemical properties of the API’s tend to show low oral bioavailability which leads to enhanced dosage and consequent adverse profiles of the drugs to the patients. Eprosartan mesylate (EM), an angiotensin II antagonist, is used in the treatment of hypertension exhibits poor bioavailability (13%) due to low absorption window. Hence we recently reported pharmaceutical cocrystals of EM (EM-SUC, EM-SAL & EM- PABA) with improved solubility and dissolution profiles. The present abstract focuses on the study of enhanced oral bioavailability of the EM cocrystals. Pharmacokinetic studies of EM cocrystals were performed using animal models (male Wister rats) to evaluate bioavailability of the drug. Four groups (n=6) of rodents were orally administered with pure EM (API suspended in water) and EM cocrystals (12.3 mg/ kg body weight in aq. solution) respectively. Serial blood samples were collected at predetermined time points and were analyzed for EM plasma concentration using a validated HPLC assay method. Pharmacokinetic and statistical data analysis was performed using Kinetica 5.0 and GraphPad Prism software. The results suggested that the EM cocrystals showed enhanced AUC and Cmax than the pure drug. Mean retention time of the cocrystals was observed to be high with low clearance values which suggest the enhanced absorption window of the prepared cocrystals. EM-SUC showed more than 3 times (3.4 fold) enhancement in the relative oral bioavailability than the pure EM suggesting that the succinic acid as preferred coformer for the preparation of the EM cocrystals.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jaswanth Santosh Bhandaru”
- BylineArticles whose byline prints “Raghuram R Akkinepally”